Author: Manning Cheng

GenXys Inks Software Deal with CareWell Health for Precision Medicine

Vancouver, Canada (June 20, 2023) – GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, finalized another customer deal to advance precision medicine initiatives. This latest partnership, with New Jersey-based CareWell Health, will help…

Read More

Updates to Dementia – Alzheimer’s, Insomnia, and Ulcerative Colitis 

Updates to Dementia – Alzheimer’s, Insomnia, and Ulcerative Colitis All TreatGx users now have access to the updated treatment algorithms for Dementia – Alzheimer’s [1-7], Insomnia [8], and Ulcerative Colitis [9-11]. As always, all updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics,…

Read More

GenXys Highlights Record Sales Quarter for Q1-2023 in Parallel with US State PGx Initiatives

Vancouver, Canada (May 30th, 2023) – GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, announces record year-over-year quarterly sales growth for Q1 2023, as well as a record implementation time for getting its…

Read More

GenXys and Dendi Join Forces to Revolutionize Pharmacogenomic Testing and Clinical Decision Support in Healthcare

North Carolina – GenXys and Dendi have announced a partnership to provide comprehensive test results and clinical decision support to clinicians nationwide. The collaboration will deliver a tightly-integrated solution that utilizes a technology-driven workflow to interpret pharmacogenomic (PGx) results and recommend…

Read More

Above and Beyond Quality Control: The Importance of Software Testing at GenXys

GenXys, being a global software as a service (SaaS) company, provides solutions to healthcare providers and labs who are looking for reliable pharmacogenetics (PGx) implementations with smart clinical decision support. One of our core values is quality, which means providing software…

Read More

GenXys Healthcare Systems™ supports Precision Medicine through partnership with Microsoft Azure™

Offering safety, security and peace of mind for advanced healthcare teams and their molecular labs GenXys provides the world’s most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare’s biggest challenges: inappropriate (“trial-and-error”) prescribing. Adverse drug reactions are…

Read More

TrueScripts and GenXys Partner to Accelerate Precision Medicine Adoption

Vancouver, Canada – GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, recently secured a customer deal with Indiana-based TrueScripts, a thriving pharmacist-founded Prescription Benefit Management (PBM) company. Together, this high-quality partnership will advance precision medicine initiatives and…

Read More

Update to NUDT15

NUDT15 update With the recent Crohn’s Disease update, we have also updated the way our software processes NUDT15 genetic data. Previously, the software assessed reported genotypes for NUDT15 rs116855232. With this update, we now assess drug-gene interactions with NUDT15 based on…

Read More

Update to Crohn’s Disease

All TreatGx users now have access to the updated Crohn’s disease treatment algorithm. Crohn’s Disease This comprehensive update incorporates information from AGA 2021[1] and ACG 2018[2] to help clinicians personalize treatment for their patients. A key update to this algorithm is…

Read More

Update to Chronic Obstructive Pulmonary Disease (COPD) – Acute Exacerbation

TreatGx users now have access to the updated treatment algorithm for Chronic Obstructive Pulmonary Disease (COPD) – Acute Exacerbation. As always, this update includes the TreatGx standard of providing personalized dosing based on kidney function, liver function, and drug interactions. This…

Read More